House Floor Summary

On motion to suspend the rules and pass the bill Agreed to by the Yeas and Nays: (2/3 required): 368 - 0 (Roll no. 329).

ONE MINUTE SPEECHES - The House proceeded with further one minute speeches.

Motion to reconsider laid on the table Agreed to without objection.

Considered as unfinished business. H.R. 4960 — "To designate the facility of the United States Postal Service located at 511 East Walnut Street in Columbia, Missouri, as the "Spc. Sterling William Wyatt Post Office Building"."

Motion to reconsider laid on the table Agreed to without objection.

Considered as unfinished business. H.R. 4946 — "To designate the facility of the United States Postal Service located at 1075 North Tustin Street in Orange, California, as the "Specialist Trevor A. Win'E Post Office"."

UNFINISHED BUSINESS - The Chair announced that the unfinished business was on motions to suspend the rules, which had been debated earlier and on which further proceedings had been postponed.

Mr. Rogers (KY) filed a report from the Committee on Appropriations on H.R. 6385.

Motion to reconsider laid on the table Agreed to without objection.

On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.

DEBATE - The House proceeded with forty minutes of debate on H.R. 5554.

Considered under suspension of the rules.

Mr. Mullin moved to suspend the rules and pass the bill, as amended. H.R. 5554 — "To amend the Federal Food, Drug, and Cosmetic Act to reauthorize user fee programs relating to new animal drugs and generic new animal drugs."

Motion to reconsider laid on the table Agreed to without objection.

On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.

DEBATE - The House proceeded with forty minutes of debate on H.R. 5333.

Considered under suspension of the rules.

Mr. Latta moved to suspend the rules and pass the bill, as amended. H.R. 5333 — "To amend the Federal Food, Drug, and Cosmetic Act to clarify the regulatory framework with respect to certain nonprescription drugs that are marketed without an approved new drug application, and for other purposes."

Motion to reconsider laid on the table Agreed to without objection.

On motion to suspend the rules and pass the bill Agreed to by voice vote.